7. Ino Y, Kubo T, Tanaka A, et al. Difference of culprit lesion morphologies between ST-segment elevation myocardial infarction and non-ST-segment elevation acute coronary syndrome: an optical coherence tomography study. JACC Cardiovasc Interv 2011;4:...
14. Roffi M, Patrono C, Collet JP, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of th...
据统计CAD影响了全球1.72%的人口,被认为是主要死亡原因,尤其是急性ST段抬高型心肌梗死(ST-segment elevation acute myocardial infarction,STEMI)和非ST段抬高型急性冠脉综合征(Non-ST-segment elevation acute coronary syndrome,NSTE-ACS)...
Background The current ST-elevation myocardial infarction (STEMI) vs. non-STEMI (NSTEMI) paradigm prevents some NSTEMI patients with acute coronary occlusion from receiving emergent reperfusion, in spite of their known increased mortality compared with NSTEMI without occlusion. We have proposed a new ...
在过去30年里,与非ST段抬高型心肌梗死(NSTEMI)相比,美国 ST段抬高型心肌梗死(STEMI) 的住院人数显著下降。据报道,因急性冠脉综合征(ACS)入院就诊的患者中,38%存在STEMI。随着治疗药物及相关技术的进步,STEMI患者的预后结果已有所改善。不过,STEMI的整体发病率及死亡率仍然较高,且给医疗体系带来了较重的经济负担,...
[2] O'Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA Guideline for the management of ST-Elevation myocardial infarction: Executive Summary: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation, 2013,127: 529...
由于临床上ST段型抬高心肌梗死(STEMI)溶栓后的患者使用替格瑞洛的出血安全性如何并不清楚,因此目前的指南均不建议在STEMI患者应用替格瑞洛。 ACC2018发布了一项在STEMI患者溶栓后随机对比替格瑞洛与氯吡格雷的临床研究 - TREAT(Administration of TicagRElor in pAtients with ST elevation myocardial infarction treated ...
近日,阜外医院杨跃进、高晓津、乔树宾、吴超等对中国心肌梗死注册(CAMI)研究的一项新分析表明,中国县级医院中,对于ST段抬高型心肌梗死(STEMI)患者,接受急诊介入治疗的患者2年死亡率仅6.8%,而未再灌注治疗的患者2年死亡率为30%。 作者指出,在县级医院,接受急诊PCI的患者长期死亡率与来自进行大中心的现实世界研究相当...
今年,韩雅玲院士团队在Lancet上发表了题为“Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention:a randomised trial”的研究(简称BRIGHT-4),再一次论证了“比伐芦定高剂量延长注射”抗凝方案...
6. Guido Parodi , Benedetta Bellandi , Ioanna Xanthopoulou. et al. Morphine Is Associated With a Delayed Activity of Oral Antiplatelet Agents in Patients With ST-elevation Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Circ Cardiovasc Interv. 2014 Dec 31;8(1):e001...